d marketing personnel Clarient's ability to maintain compliance with financial and other covenants under its credit facility <a href="http://www.bio-medicine.org/inc/biomed/biology-technology.asp">http://www.bio-medicine.org/inc/biomed/biology-technology.asp</a> http://feeds.bio-medicine.org/latest-biology-technologyDate:11/5/2010 the proposed transaction, Clarient's ability to continue to develop and expand its diagnostic services business, uncertainties inherent in Clar